Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Association of the LILRA3 deletion with B-NHL and functional characterization of the immunostimulatory molecule.

Low HZ, Reuter S, Topperwien M, Dankenbrink N, Peest D, Kabalak G, Stripecke R, Schmidt RE, Matthias T, Witte T.

PLoS One. 2013 Dec 9;8(12):e81360. doi: 10.1371/journal.pone.0081360. eCollection 2013.

2.

[Therapy of multiple myeloma. What is confirmed?].

Peest D, Ganser A, Einsele H.

Internist (Berl). 2013 Dec;54(12):1434, 1436-8, 1440-2. doi: 10.1007/s00108-013-3323-7. Review. German.

PMID:
24201762
3.

High cut-off dialysis as a salvage therapy option in high-dose methotrexate chemotherapy?

Bertram A, Ivanyi P, Hafer C, Matthias K, Peest D, Ganser A, Schmidt BM.

Ann Hematol. 2014 Jun;93(6):1053-5. doi: 10.1007/s00277-013-1909-8. Epub 2013 Oct 6. No abstract available.

PMID:
24097083
4.

Effects of platelet concentrate storage time reduction in patients after blood stem cell transplantation.

Heuft HG, Goudeva L, Krauter J, Peest D, Buchholz S, Tiede A.

Vox Sang. 2013 Jul;105(1):18-27. doi: 10.1111/vox.12015. Epub 2013 Mar 22.

PMID:
23521355
5.

B-cell lymphoma infiltration of cerebrospinal fluid with minimal symptoms and benign course.

Skripuletz T, Pul R, Wurster U, Peest D, Dengler R, Stangel M.

J Clin Neurosci. 2011 Jul;18(7):978-80. doi: 10.1016/j.jocn.2010.11.019. Epub 2011 May 11.

PMID:
21565511
6.

Legionnaires' disease in immunocompromised patients: a case report of Legionella longbeachae pneumonia and review of the literature.

Kümpers P, Tiede A, Kirschner P, Girke J, Ganser A, Peest D.

J Med Microbiol. 2008 Mar;57(Pt 3):384-7. doi: 10.1099/jmm.0.47556-0. Review.

PMID:
18287305
7.

[Therapy of multiple myeloma: indications and options].

Peest D, Ganser A.

Internist (Berl). 2007 Dec;48(12):1343-8. Review. German.

PMID:
17960351
8.

Adult onset of T-cell deficiency with impaired CD2 expression complicated by Rhodococcus infection: a case report.

Kittner JM, Jacobs R, Buyny S, Peest D, Stoll M, Schmidt RE.

Ann Allergy Asthma Immunol. 2007 Mar;98(3):294-8.

PMID:
17378264
9.

Myeloma--new approaches to combined nephrological-haematological management.

Haubitz M, Peest D.

Nephrol Dial Transplant. 2006 Mar;21(3):582-90. Epub 2006 Jan 5. Review. No abstract available.

PMID:
16396976
10.

Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells.

Morgan MA, Sebil T, Aydilek E, Peest D, Ganser A, Reuter CW.

Br J Haematol. 2005 Sep;130(6):912-25.

PMID:
16156861
11.

A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma.

Einsele H, Bamberg M, Budach W, Schmidberger H, Hess CF, Wörmann B, Meisner C, Straka C, Hebart H, Trümper L, Kröger N, Zander AR, Hegewisch-Becker S, Hossfeld DK, Schmidt H, Müller P, Schlimok G, Hertenstein B, Peest D, Metzner B, Frickhofen N, Kanz L, Bensinger WI.

Bone Marrow Transplant. 2003 Sep;32(6):593-9.

PMID:
12953132
12.

[Multilocular Castleman's Disease of the mixed type. An rare differential diagnosis in lymphadenopathy with weakness, weight loss and night-sweats].

Röhrig G, Engel H, Noack F, Ganser A, Peest D.

Dtsch Med Wochenschr. 2001 Sep 28;126(39):1070-2. German.

PMID:
11602914
13.

The role of alpha-interferon in multiple myeloma.

Peest D.

Pathol Biol (Paris). 1999 Feb;47(2):172-7.

PMID:
10192884
14.

Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer.

Franzke A, Peest D, Probst-Kepper M, Buer J, Kirchner GI, Brabant G, Kirchner H, Ganser A, Atzpodien J.

J Clin Oncol. 1999 Feb;17(2):529-33. Erratum in: J Clin Oncol 1999 Apr;17(4):1330.

PMID:
10080596
15.

[Prognostic factors and standard therapy of multiple myeloma].

Peest D.

Praxis (Bern 1994). 1998 Jun 24;87(25-26):874-8. German.

PMID:
9702090
16.

Pyridinium cross-links in multiple myeloma: correlation with clinical parameters and use for monitoring of intravenous clodronate therapy--a pilot study of the German Myeloma Treatment Group (GMTG).

Peest D, Deicher H, Fett W, Harms P, Braun HJ, Planker M, Kindler U, Klinkenstein C, Schäfer E, Schumacher K, Siecke H.

Eur J Cancer. 1996 Nov;32A(12):2053-7.

PMID:
9014744
17.

Cytokine therapy in multiple myeloma.

Peest D, Bladé J, Harousseau JL, Klein B, Osterborg A, San Miguel JF.

Br J Haematol. 1996 Sep;94(3):425-32. Review. No abstract available.

PMID:
8790137
19.

[Multiple myeloma].

Peest D.

Ther Umsch. 1996 Feb;53(2):147-51. Review. German.

PMID:
8629265
20.

Supplemental Content

Loading ...
Support Center